Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human coagulation factor VIII in hemophilia A
CTR20170302Phase 3Active
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antihemophilic factor human in hemophilia A, sponsored by Wuhan Institute of Biological Products. Started Jan 2018; status: active.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20170302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170302.